Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2012
03/29/2012WO2012040444A2 Treatment of patients with incipient alzheimer's disease
03/29/2012WO2012040404A1 Monohydrate of an azaadamantane derivative
03/29/2012WO2012040279A1 Modulators of the gpr119 receptor and the treatment of disorders related thereto
03/29/2012WO2012040258A2 Therapeutic piperazines
03/29/2012WO2012040242A1 Substituted proline inhibitors of hepatitis c virus replication
03/29/2012WO2012040230A1 Imidazotriazinone compounds
03/29/2012WO2012040229A1 Corticosteroid particles and method of production
03/29/2012WO2012040177A1 Methods and compositions for treatment of diabetes and dyslipidemia
03/29/2012WO2012040170A2 Compositions and methods for treating tuberculosis
03/29/2012WO2012040139A1 Oxadiazole inhibitors of leukotriene production
03/29/2012WO2012040137A1 Oxadiazole inhibitors of leukotriene production
03/29/2012WO2012040127A1 Substituted nucleotide analogs
03/29/2012WO2012040126A1 Substituted nucleotide analogs
03/29/2012WO2012040124A1 Azido nucleosides and nucleotide analogs
03/29/2012WO2012040082A2 Antidiabetic solid pharmaceutical compositions
03/29/2012WO2012040048A2 Triazolopyrazinones as p2x7 receptor antagonists
03/29/2012WO2012040040A1 Hcv ns3 protease inhibitors
03/29/2012WO2012039972A1 Pharmaceutical composition
03/29/2012WO2012039855A1 Ph-sensitive compositions for delivery of beta lapachone and methods of use
03/29/2012WO2012039793A1 Methods and compositions for treating lung cancer
03/29/2012WO2012039791A1 2' -fluoro substituted carba-nucleoside analogs for antiviral treatment
03/29/2012WO2012039787A1 2' -fluoro substituted carba-nucleoside analogs for antiviral treatment
03/29/2012WO2012039768A2 Itraconazole formulations
03/29/2012WO2012039741A1 Novel block copolymer and micelle compositions and methods of use thereof
03/29/2012WO2012039718A1 Novel dihydropyrimidin-2(1h)-one compounds as neurokinin-3 receptor antagonists
03/29/2012WO2012039717A1 Hepatitis c virus inhibitors
03/29/2012WO2012039691A2 Synergic effect
03/29/2012WO2012039660A1 Phenylpiperidine compounds for the treatment of neurological and psychiatric disorders
03/29/2012WO2012039657A1 Novel chromane compound for the treatment of pain disorders
03/29/2012WO2012039642A1 Pharmaceutical composition having antimicrobial and fast-healing activity for external administration, process for preparing same
03/29/2012WO2012039641A1 Pharmaceutical composition having antimicrobial and anti-inflammatory activity for parenteral administration, process for preparing same
03/29/2012WO2012039639A1 Composition for normalizing microflora and purifying an organism from toxins and method for sanitation of an organism
03/29/2012WO2012039596A2 Pharmaceutical compositions for calanolides, their derivatives and analogues, and process for producing the same
03/29/2012WO2012039472A1 Drug against central nervous system inflammation
03/29/2012WO2012039469A1 Method for screening binding inhibitor of rage and age
03/29/2012WO2012039460A1 Substituted amide compound
03/29/2012WO2012039447A1 Crystals of substituted cycloalkene derivatives
03/29/2012WO2012039414A1 Substituted polycyclic carbamoyl pyridone derivative prodrug
03/29/2012WO2012039371A1 Cyclopropane compound
03/29/2012WO2012039197A1 Agent for enhancing trail sensitivity
03/29/2012WO2012039137A2 A nucleic acid having an anti-metabolic syndrome effect
03/29/2012WO2012038971A2 Novel polymorphs of febuxostat
03/29/2012WO2012038944A1 Matrix metalloproteinase inhibitors
03/29/2012WO2012038943A1 Matrix metalloproteinase inhibitors
03/29/2012WO2012038942A1 Matrix metalloproteinase inhibitors
03/29/2012WO2012038937A1 Aprepitant l-proline composition and cocrystal
03/29/2012WO2012038905A1 Thienopyridine nicotinamide derivatives, preparation thereof and therapeutic use thereof
03/29/2012WO2012038904A1 Nicotinamide derivatives, preparation thereof and therapeutic use thereof
03/29/2012WO2012038898A1 Pharmaceutical formulations containing rifaximin, processes for their obtainment and method of treating intestinal disease
03/29/2012WO2012038851A1 Isoxazoline oximes as antiparasitic agents
03/29/2012WO2012038850A1 Pyridmidones for treatment of potassium channel related diseases
03/29/2012WO2012038813A1 Buprenorphine analogs
03/29/2012WO2012038785A1 Polymorphs of rosuvastatin acetonide calcium ((3r,5s,6e)-7-[4-(4- fluorophenyl)-6-isopropyl-2-(methanesulfonyl-methyl-amino)-pyrimn)in-5- yl)vinyl)-2,2-dimethyl-l,3-dioxan-4-yl) acetic acid calcium salt
03/29/2012WO2012038759A1 Sirna against p22phox
03/29/2012WO2012038743A1 Pyrazolopyridines as inhibitors of the kinase lrrk2
03/29/2012WO2012038694A1 Anti-cancer compounds
03/29/2012WO2012038636A1 Xenon-based anesthetic gas composition usable during an endarterectomy involving the clamping of the carotid artery
03/29/2012WO2012038605A1 Viral therapy enhancing adjuvant
03/29/2012WO2012038590A1 Improved dietary substitution for treating or preventing cancer
03/29/2012WO2012038553A1 Viral inhibitor composition for in vivo therapeutic use
03/29/2012WO2012038512A2 Composition comprising sod, lutein and zeaxanthin
03/29/2012WO2012038492A1 Novel substituted amino-, imino-1,2,4 triazine derivatives
03/29/2012WO2012038438A1 4,7-DIHYDRO-PYRAZOLO[1,5-a]PYRAZIN-6-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE)
03/29/2012WO2012038417A1 Substituted amino - benzoic acid derivatives as inhibitors of dna methyltransferases
03/29/2012WO2012038371A1 Caspofungin composition
03/29/2012WO2012038307A1 Spiro substituted pyrrolo[1,2-c]imidazole derivatives useful as mdm2 inhibitors
03/29/2012WO2012038251A1 Use of boswellic acids for the prophylaxis and/or treatment of damages and/or inflammation of the islets of langerhans
03/29/2012WO2012038097A1 Use of a new class of nucleotide sugar as antibiotic or cytostatic agent
03/29/2012WO2012038058A1 Treatment of conditions by toll-like receptor modulators
03/29/2012WO2012037834A1 5α-ANDROSTANE (ALKYL)-3β,5,6β-TRIOL INJECTION AND PREPARATION METHOD THEREFOR
03/29/2012WO2012037782A1 Tricyclic compounds, preparation methods, and their uses
03/29/2012WO2012037665A1 Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
03/29/2012WO2012037634A1 Compounds and pharmaceutical compositions for treating disorders associated with the 5-ht1a and 5-ht2a receptors
03/29/2012WO2012019203A3 Therapeutic agent for intranasal administration and method of making and using same
03/29/2012WO2012018145A3 Agent for improving quality of life
03/29/2012WO2012017434A3 Guanine nucleotide derivatives for treating bacterial infections
03/29/2012WO2012017430A3 Microrna patterns for the diagnosis, prognosis and treatment of melanoma
03/29/2012WO2012017321A3 Treatment for dyslipidemia
03/29/2012WO2012017288A3 Supramolecular complexes of polyanionic polymers and spermidine in tissue maintenance and repair
03/29/2012WO2012016980A3 Use of sigma ligands in opioid-induced hyperalgesia
03/29/2012WO2012014085A8 Uses of cimiracemate a and related compounds for treating inflammation and modulating immune responses
03/29/2012WO2012013756A3 Method for preparing tablets combining rifampicin, isoniazid, pyrazinamide and, optionally, ethambutol
03/29/2012WO2012013282A8 Bicyclic azaheterocyclic carboxamides as inhibitors of the kinase p70s6k
03/29/2012WO2012009678A8 Therapeutically active compositions and their method of use
03/29/2012WO2012003563A4 Antineoplastic pharmaceutical compositions containing substituted nitroaromatic compounds
03/29/2012WO2012003562A4 Antineoplastic pharmaceutical compositions containing substituted nitroimidazoles
03/29/2012WO2012001411A3 Pharmaceutical compositions for sublingual delivery of opioids
03/29/2012WO2012001065A3 Use of alpha-adrenergic receptor agonist for preventing or treating skin tumor
03/29/2012WO2011163198A3 Tg2 inhibitors and uses thereof
03/29/2012WO2011153553A3 Methods and compositions for kinase inhibition
03/29/2012WO2011152671A3 Pharmaceutical composition for the prevention or treatment of inflammatory diseases or immune diseases containing ramalin
03/29/2012WO2011150160A9 Method of preventing and treating inflammatory diseases and disorders with abscisic acid
03/29/2012WO2011149213A3 Novel derivative having inhibitory activity against 11β-hsd1, preparation method thereof, and pharmaceutical composition containing same as active ingredient
03/29/2012WO2011146560A3 Use of jasmonates for treating heart failure and related cardiac disorders
03/29/2012WO2011146030A3 Effervescent antihistamine formulations
03/29/2012WO2011145909A3 Novel use of panduratin derivatives or an extract of boesenbergia pandurata for promoting muscle mass growth, fighting fatigue, and enhancing exercise performance capability
03/29/2012WO2011143669A3 Compositions and methods for treating neoplasia, inflammatory disease and other disorders
03/29/2012WO2011143579A9 Cancer prevention and treatment methods based on dietary polyamine content
03/29/2012WO2011141822A3 Methods for induction, predictive diagnosis, and treatment of affective behaviors by modulation of ppar and rxr receptors
03/29/2012WO2011140527A3 Methods and compositions for inhibition of the transitional endoplasmic reticulum atpase
1 ... 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 ... 7860